GlobeNewswire (Mon, 9:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
674 people get WCRX articles and Market Currents by email alert.
Get email alerts on WCRX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
GlobeNewswire (May 13, 2013)
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 10, 2013)
-
-
GlobeNewswire (May 9, 2013)
-
-
-
GlobeNewswire (May 7, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (May 1, 2013)
-
GlobeNewswire (Apr 22, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Warner Chilcott Reports Earnings FridayRobert Weinstein • Wed, Aug 3, 2011 -
-
Warner Chilcott Beats on Earnings, Ups OutlookZacks Investment Research • Wed, Nov 17, 2010 -
Warner Chilcott: Prescription Drug Company Offering Exceptional ValueZachary Scheidt • Sun, Mar 21, 2010 -
Leverage Datapoint of the DayFelix Salmon • Tue, Sep 22, 2009 -
Warner Chilcott Settles Antitrust Suits On Oral ContraceptiveAaron F. Barkoff • Tue, Apr 17, 2007 -
Warner Chilcott: ValueAct Capital Discloses 5.5% StakeLon Juricic • Sun, Feb 25, 2007
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Top 5 Insider Sells Filed On September 13Markus Aarnio • Fri, Sep 14, 2012
-
Warner Chilcott CEO Discusses 2012 Guidance (Transcript)Fri, Jan 27, 2012 • 1 Comment
-
Warner Chilcott Ltd. Q4 2008 Earnings Call TranscriptFri, Feb 27, 2009
-
Warner Chilcott Limited 2009 Financial Guidance Call TranscriptTue, Jan 27, 2009
-
Warner Chilcott Limited Q3 2008 Earnings Call TranscriptMon, Nov 10, 2008
-
Warner Chilcott Limited Q2 2008 Earnings Call TranscriptFri, Aug 8, 2008
-
Warner Chilcott Limited Q1 2008 Earnings Call TranscriptFri, May 9, 2008
-
Warner Chilcott Ltd. Q4 2007 Earnings Call TranscriptFri, Feb 29, 2008
-
Warner Chilcott Limited Q3 2007 Earnings Call TranscriptSun, Nov 11, 2007
-
at MarketWatch.com (Mon, 4:38PM)
-
at MarketWatch.com (Mon, 4:33PM)
-
at CNBC.com (Mon, 4:27PM)
-
GlobeNewswire (Mon, 9:00AM)
-
at CNBC.com (Mon, 8:48AM)
-
at MarketWatch.com (Mon, 8:46AM)
-
at CNBC.com (Mon, 8:00AM)
-
at Fox Business (Mon, 7:30AM)
-
at Fox Business (Mon, 7:30AM)
-
at Fox Business (Mon, 7:23AM)
-
GlobeNewswire (May 13, 2013)
-
at MarketWatch.com (May 10, 2013)
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (May 7, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (May 1, 2013)
-
GlobeNewswire (Apr 22, 2013)
WCRX vs. ETF Alternatives
Company Description
We are a leading global specialty pharmaceutical company currently focused on the gastroenterology, women’s healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals markets. We are a fully integrated company with internal resources dedicated to the... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, May 20, 7:15 AM Actavis (ACT) confirms it will buy Warner Chilcott (WCRX) for $8.5B in a stock for stock transaction. The deal will see Warner Chilcott shareholders receive 0.160 shares of the "new" Actavis for each Warner Chilcott share they own. The combined company will become the third-largest specialty pharmaceutical player in the U.S. 1 Comment [Healthcare, M&A]
- Monday, May 20, 7:08 AM Shares of Warner Chilcott (WCRX) are halted with news pending. Comment! [Healthcare]
- Friday, May 17, 2:34 PM Actavis' (ACT +1.5%) pursuit of Warner Chilcott (WCRX +0.5%) may be a way to defend itself from a potential takeovers by Valeant Pharmaceuticals (VRX +2.5%) and Mylan (MYL +2.2%). VRX routinely looks at potential acquisitions, but to date has stayed away from WCRX because of its dwindling pipeline, so a combined ACT/WCRX deal would be out of the picture. And it would be virtually impossible for MYL, with a market value of $11.7B, to buy the combined firm. It already has about $6B in debt and Street estimates put a combined companies near $21B. Comment! [Healthcare, M&A]
- Wednesday, May 15, 8:28 PM Actavis (ACT), which has rebuffed overtures from both Valeant (VRX) and more recently Mylan (MYL), may soon receive a bid from Novartis (NVS), WSJ says. "Intense price competition and fewer opportunities to cash in on patent expirations," are fueling a consolidation scramble in the generic-drug industry, the Journal notes, and ACT — which is also playing the role of acquirer in negotiations with Warner Chilcott (WCRX) — is at the center of the deal-making rumor mill. Comment! [Healthcare]
- Monday, May 13, 3:01 PM Buckingham joins in on the Warner Chilcott (WCRX +6%)/Activis (ACT -0.3%) lovefest, upping its price target on Warner to $24, adding that it sees the potential for a debt-financing deal as high as $30 per share for the company. Comment! [Healthcare, On the Move]
- Monday, May 13, 8:11 AM The sell-side loves the Warner Chilcott/Actavis deal, with Morgan Stanley, UBS, and CRT Capital all giving their blessing. UBS sees 50-60% accretion in 2015 and thinks the deal gets done about $23/share. WCRX +5.1% premarket. ACT closed Friday at $119.86. Comment! [Healthcare, M&A]
- Friday, May 10, 3:07 PM Shares of Activis (ACT +11.4%) and Warner Chilcott (WCRX +24.2%) both resume trading. Comment! [Healthcare, M&A, On the Move]
- Friday, May 10, 3:02 PM Shares of Activis (ACT +11.9) and Warner Chilcott (WCRX +11%) both remain halted after confirming they are in merger talks. Shares are due to resume trading shortly. Comment! [Healthcare, On the Move, M&A]
-
Friday, May 10, 12:52 PM
Midday top 10 gainers: UNIS +58%. DRAM +57%. VRML +26%. SREV +22%. MCP +20%. UBNT +18%. RH +18%. WCRX +17%. CSIQ +16%. SQNM +16%.
Midday top 10 losers: PTIE -48%. DRRX -41%. IFMI -34%. AFFY -26%. SRT -23%. LPDX -22%. OPTR -17%. REFR -16%. PANL -16%. TRMD -15%. Comment! [On the Move] - Friday, May 10, 12:40 PM More on Actavis (ACT +6.1%) / Warner Chilcott (WCRX +12.3%): The news comes just weeks after ACT broke off merger talks with Valeant Pharmaceuticals (VRX +0.5%) after balking at the premium it was offered. Now, considering the strength of ACT's recent Q1 report, that deal looks dead. Warner, on the other hand, had disclosed over a year ago that it was pursuing a sale. Comment! [Healthcare, M&A, On the Move]
- Friday, May 10, 12:17 PM Shares of Actavis (ACT +3%) spike higher on reports the company is in early-stage talks to acquire Warner Chilcott (WCRX +9.5%). Comment! [Healthcare, M&A, On the Move]
- Friday, May 10, 7:59 AM Warner Chilcott (WCRX): Q1 EPS of $0.45. Revenue of $593M beats by $4.94M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Friday, May 10, 12:05 AM Notable earnings before Friday’s open: AWR, DRH, EVEP, HL, MT, PGNX, TRLG, VTG, WCRX Comment! [Earnings]
- Thursday, May 9, 5:30 PM Notable earnings before Friday’s open: AWR, DRH, EVEP, HL, MT, PGNX, TRLG, VTG, WCRX Comment! [Earnings]
- Wednesday, May 8, 9:04 AM Warner Chilcott (WCRX) declares $0.25/share semi-annual dividend, in line with previous. Forward yield 3.34%. For shareholders of record May 31. Payable June 14. Ex-div date May 29. (PR) Comment! [Dividends]
- Friday, April 12, 8:44 AM Warner Chilcott (WCRX) receives FDA approval for delayed-release 200 mg DORYX tablets (tetracycline) and will launch the product in July. Comment! [Healthcare]
-
- View all 0 replies
-
Ryan Mallory
Fuinhaz Setups for May 13 2013 | $TSRX $UNIS $WCRX | SharePlanner http://bit.ly/17Xh5h3 - View all 0 replies
-
Kapitall
Income Idea: 2 Undervalued Drug Makers With Rising Gross Profit Margins $SCLN $WCRX http://seekingalpha.com/a/ui5n - View all 0 replies
-
Dividend Sheet
$PDLI $WCRX and $QCOR are the best Yielding Cheap Healthcare Dividend Stocks - http://stks.co/dSSu - 20 stocks 2.66% at Yield $MDT $PFE - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Dustin Moore
$APRI SEC filing suggests positive guidance re $WCRX Vitaros ED drug http://bit.ly/SKQqhl - View all 0 replies
-
MagicDiligence
Warner Chilcott $WCRX shares down 10% after ownership funds dumping 17% of the company. Stock looks really cheap to me, odd. - View all 0 replies
LATEST REPLIES
-
Michael Bryant
Rumor of buyout of Warner Chilcott plc (WCRX) by Bayer at "$32 per share." Buy the rumor, sell the news. http://bit.ly/ImG3xE - View all 1 replies
-
